Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paragon 28 (FNA)
NYSE:FNA
Paragon 28 (FNA) Stock Price & Analysis
51 Followers
FNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.55 - $18.50
Previous Close$6.66
Volume343.21K
Average Volume (3M)698.75K
Market Cap
$552.46M
Enterprise Value$587.26M
Total Cash (Recent Filing)$75.64M
Total Debt (Recent Filing)$110.44M
Price to Earnings (P/E)―
Beta1.25
Next Earnings
Jul 31, 2024EPS Estimate
-$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding82,951,360
10 Day Avg. Volume884,262
30 Day Avg. Volume698,746
Standard Deviation0.13
R-Squared0.19
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)3.65
Price to Sales (P/S)7.86
Price to Cash Flow (P/CF)-7.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.71
Enterprise Value/Gross Profit3.40
Enterprise Value/Ebitda-104.77
Forecast
1Y Price Target
$16.20Price Target Upside143.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Paragon 28 News
PremiumCompany Announcements
Paragon 28 Shares Strategic and Financial Outlook Update
Bulls Say, Bears Say
Bulls Say
Financial PerformancePreliminary Q1 revenues exceeded estimates, indicating strong financial performance.
Growth PotentialParagon 28 remains positioned to dominate in the foot and ankle niche that is not as critical for larger players that concentrate primarily on hips, knees, and spine.
Market PositionParagon 28 is reaching its growth stride and making headway toward profitability, all while taking share in the fastest-growing segment of the orthopedic market.
Bears Say
Financial PerformanceAdjusted EBITDA loss came in at $5.5 million, significantly worse than the Street's expectation of -$2.6 million.
ManagementStephen Deitsch has resigned as Chief Financial Officer, creating potential uncertainty despite an interim solution being in place.
ProfitabilityProfitability was softer than expected, as increased operational expenses resulted in a widening of the adjusted EBITDA loss.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
FNA FAQ
What was Paragon 28’s price range in the past 12 months?
Paragon 28 lowest stock price was $5.55 and its highest was $18.50 in the past 12 months.
What is Paragon 28’s market cap?
Currently, no data Available
When is Paragon 28’s upcoming earnings report date?
Paragon 28’s upcoming earnings report date is Jul 31, 2024 which is in 23 days.
How were Paragon 28’s earnings last quarter?
Paragon 28 released its earnings results on May 08, 2024. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.123 by -$0.057.
Is Paragon 28 overvalued?
According to Wall Street analysts Paragon 28’s price is currently Undervalued.
Does Paragon 28 pay dividends?
Paragon 28 does not currently pay dividends.
What is Paragon 28’s EPS estimate?
Paragon 28’s EPS estimate is -$0.17.
How many shares outstanding does Paragon 28 have?
Paragon 28 has 82,951,360 shares outstanding.
What happened to Paragon 28’s price movement after its last earnings report?
Paragon 28 reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.123. Following the earnings report the stock price went down -13.158%.
Which hedge fund is a major shareholder of Paragon 28?
Among the largest hedge funds holding Paragon 28’s share is Woodline Partners LP. It holds Paragon 28’s shares valued at 2M.
---
Paragon 28 Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.20 (143.24% Upside)
$16.20 (143.24% Upside)
Hedge Fund Trend
Decreased
By 355.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.32%
12-Months-Change
Fundamentals
Return on Equity
-29.23%
Trailing 12-Months
Asset Growth
6.71%
Trailing 12-Months
Company Description
Paragon 28
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, charcot, fracture fixation, hallux valgus, hammertoe, and flatfoot.
---
FNA Company Deck
---
FNA Earnings Call
Q1 2024
0:00 / 0:00
---
FNA Stock 12 Month Forecast
Average Price Target
$16.20
▲(143.24% Upside)
Technical Analysis
Best Analysts Covering FNA
1 Year
1 Year Success Rate
2/9 ratings generated profit
1 Year Average Return
-23.39%
reiterated a buy rating 2 months ago
Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -23.39% per trade.
---